Integra Lifesciences Holdings (IART) Return on Capital Employed Growth (3y) (2013 - 2026)
Integra Lifesciences Holdings (IART) Return on Capital Employed Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -1,679.00 |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 214.00 |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 145.00 |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 355.00 |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -846.00 |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 1,318.00 |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -247.00 |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Integra Lifesciences Holdings | 1.50 Bn | 1.23 Bn | 216.98 Mn | -2,087.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,087.00 |
| Dec 31, 2025 | -2,235.00 |
| Sep 30, 2025 | -2,120.00 |
| Jun 30, 2025 | -2,354.00 |
| Mar 31, 2025 | -595.00 |
| Dec 31, 2024 | -483.00 |
| Sep 30, 2024 | -471.00 |
| Jun 30, 2024 | -396.00 |
| Mar 31, 2024 | -256.00 |
| Dec 31, 2023 | -160.00 |
| Sep 30, 2023 | -4.00 |
| Jun 30, 2023 | 361.00 |
| Mar 31, 2023 | 365.00 |
| Dec 31, 2022 | 364.00 |
| Sep 30, 2022 | 355.00 |
| Jun 30, 2022 | 182.00 |
| Mar 31, 2022 | 213.00 |
| Dec 31, 2021 | 188.00 |
| Sep 30, 2021 | 274.00 |
| Jun 30, 2021 | 327.00 |